It’s been made newly popular by singer/actress Beyonce Knowles, who used the diet to lose 20 pounds quickly for her role in the movie Dreamgirls, but the maple syrup diet, also known as the lemonade diet or the master cleanse, has been around since the 1970s.
Using the word “dietâ€? to describe the program is a […]
Alizyme’s early triumph with its obesity drug, Cetilistat, heads the highlights for the Cambridge company’s interim results.
Clinical trials are steaming ahead in both Japan and the US.
Internet Pharmacy - Buy Pharmacy at reasanoble prices.Internet Pharmacy provides confortable and easy way to order pharmacy via internet.
The drug acts in a similar way to Xenical, preventing the […]
Acomplia is primarily an anorectic drug with Rimonabant as its active component. It works on the principle of inhibiting the brain signals which regulate your appetite. Blocking of these signals, results in the reduction of appetite thus causing weight loss. ‘Acomplia Rimonabant is a new generation weight loss drug which has spread like a […]
ATLANTA — Diet pills come and diet pills go, but still the fat clings to the collective hips and bellies of 167 million of us in the United States.
Two pharmaceutical companies are hoping that two new drugs under review by the Food and Drug Administration might do what dozens before have tried but failed to […]
Two thirds of the UK population is either obese or overweight, according to research from Bristol University. That’s a worrying statistic and it suggests that demand for fat-busting products can only increase.
One UK biotech, Alizyme (LSE: AZM), has a promising anti-obesity drug called Cetilistat. It works by restricting the absorption of fat in the gut, […]
The got milk? Great American Weight Loss Challenge is visiting Pittsburgh and Market Square from 11-2PM on August 7 as part of a 75-city, cross-country tour that’s encouraging people to sign up for a plan that provides the tools to lose weight in a healthy way.
The Milk Mustache Mobile, representatives and the Mayor […]
Alizyme plc (LSE:AZM) is pleased to announce that it has concluded a successful end of Phase II meeting with the United States Food and Drug Administration (”FDA”) for cetilistat. Cetilistat is the Company’s product candidate in development for the treatment of obesity and management of related diseases such as Type II diabetes.
The meeting with the […]